Resources

Evidation Appoints Leslie Oley Wilberforce as CEO

Evidation appoints Leslie Oley Wilberforce as CEO. Wilberforce will lead Evidation’s next phase of growth in interactive real-world data and health research.

GLP-1s: Real-world insights from 10,000 users

Evidation's direct-to-participant connection is reshaping real-world insights into weight management journeys and GLP-1 usage. Explore what's possible with interactive real-world data collected directly from 10,000+ people using GLP-1s.

Evidation partners with 1upHealth to integrate diverse sources of permissioned real-world health data for research

Evidation and 1upHealth announce a long-term partnership to advance patient-centered, real-world health research.

Better data, better outcomes: Weight management

Survey + wearable data from Evidation members about their weight management experiences have highlighted real-world priorities, challenges, and opportunities in this space. Watch our Lunch & Learn to learn more.

REVEAL, a prospective, observational study

Evidation and partners aimed to examine the impact of paroxysmal nocturnal hemoglobinuria (PNH) and its treatment on patients’ daily lives by combining patient-reported outcomes with wearable technology.

Elizabeth A. Griffiths, Jae S. Min, Wei-Nchih Lee, Jeffrey C. Yu, Yogesh Patel, Karl-Johan Myren, & David Dingli

Equitable research drives equitable health care: The power of patient-reported outcomes (PROs)

Learn how integrating participant-reported outcome (PRO) data with social determinants of health (SDOH) can identify and address disparities in access to care, treatment outcomes, and satisfaction with health care.

Better data, better outcomes: Migraine

Watch our on-demand Lunch & Learn to learn what you can uncover with a richer, more longitudinal data set.

Accessibility, meaningful experiences, and seamless participation: Key considerations to foster engagement in research

Evidation's Manager of Clinical Study Start Up and Strategy sits down for a chat about successful strategies for fostering participant engagement in health research.

Precision recruitment for high-risk participants in a COVID-19 cohort study